| human | Q5 |
| P496 | ORCID iD | 0000-0002-7137-7281 |
| P166 | award received | Presidential Early Career Award for Scientists and Engineers | Q7241433 |
| P108 | employer | University of Washington School of Medicine | Q7896584 |
| P735 | given name | Sara | Q833345 |
| Sara | Q833345 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q55210146 | A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. |
| Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
| Q45305326 | A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. |
| Q36310685 | A comprehensive survey of genetic variation in 20,691 subjects from four large cohorts |
| Q35093501 | A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer |
| Q37192589 | A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication |
| Q35177444 | A genome-wide pleiotropy scan for prostate cancer risk |
| Q34113217 | A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q91119899 | A large-scale exome array analysis of venous thromboembolism |
| Q35248192 | A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q36477652 | A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease |
| Q34156268 | A multigenic approach to evaluating prostate cancer risk in a systematic replication study |
| Q33870435 | A nonparametric test to detect quantitative trait loci where the phenotypic distribution differs by genotypes |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q36083454 | ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3). |
| Q61948762 | Abstract LB-448: Genome-wide association study identifies new prostate cancer susceptibility loci |
| Q57748350 | Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study |
| Q34472668 | Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium |
| Q58116445 | Adiposity throughout the life course and risk of venous thromboembolism |
| Q29248820 | Age at natural menopause genetic risk score in relation to age at natural menopause and primary open-angle glaucoma in a US-based sample |
| Q89426501 | Alcohol consumption and the risk of incident pulmonary embolism in US women and men |
| Q89476622 | Allergy, asthma, and the risk of breast and prostate cancer: a Mendelian randomization study |
| Q37170192 | An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population |
| Q24170413 | Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types |
| Q34287725 | Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer |
| Q38772826 | Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study. |
| Q90666760 | Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium |
| Q57305944 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q36123803 | Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses |
| Q92843597 | Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study |
| Q91236415 | Association of Infection with Chronic Hepatitis C Virus and Myocardial Infarction in People Living with HIV in the United States |
| Q36191018 | Association of breast cancer risk loci with breast cancer survival |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q34314362 | Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q36792641 | Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation |
| Q63966080 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q64118820 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q85036540 | Averaged or stratified measures of risk profile discrimination: horses for courses |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q39734134 | Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States |
| Q36998293 | COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration |
| Q33842251 | Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. |
| Q34810303 | Circadian clock genes and risk of fatal prostate cancer |
| Q45071502 | Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study |
| Q27336054 | Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q36600605 | Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk |
| Q35868793 | Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3) |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q28943505 | Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer |
| Q34792833 | Common variants in ZNF365 are associated with both mammographic density and breast cancer risk |
| Q54639884 | Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP. |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q88738735 | Correction to: Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study |
| Q90263547 | Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients |
| Q28396029 | Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer |
| Q28388475 | Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations |
| Q37396372 | Deep targeted sequencing of 12 breast cancer susceptibility regions in 4611 women across four different ethnicities |
| Q61800379 | Efficient cross-trait penalized regression increases prediction accuracy in large cohorts using secondary phenotypes |
| Q57202568 | Erratum: Corrigendum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk |
| Q37475917 | Estimation of absolute risk for prostate cancer using genetic markers and family history |
| Q82903200 | Estrogen receptor beta polymorphism is associated with prostate cancer risk |
| Q64912700 | Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients. |
| Q36856343 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression |
| Q55380382 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q55311842 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. |
| Q35097143 | Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer |
| Q91396792 | Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation |
| Q92963829 | Genetic associations of breast and prostate cancer are enriched for regulatory elements identified in disease-related tissues |
| Q35999323 | Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study |
| Q108609948 | Genetic insights into biological mechanisms governing human ovarian ageing |
| Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
| Q35806601 | Genetic risk variants associated with in situ breast cancer |
| Q48345170 | Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma |
| Q44545695 | Genetic variation in the COX-2 gene and the association with prostate cancer risk |
| Q33889494 | Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer |
| Q35218136 | Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality |
| Q37127440 | Genetic variation in the upstream region of ERG and prostate cancer |
| Q36741744 | Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q91063038 | Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q28659283 | Genome-wide association study identifies multiple loci associated with bladder cancer risk |
| Q35061252 | Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk |
| Q28924380 | Genome-wide association study identifies new prostate cancer susceptibility loci |
| Q34375940 | Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25. |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q38970751 | Genome-wide association study of prostate cancer-specific survival |
| Q28943359 | Genome-wide interaction study of smoking and bladder cancer risk |
| Q59566871 | Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility |
| Q38823212 | Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk |
| Q92667373 | Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism |
| Q59265074 | Germ-Line Genetic Variation in the Key Androgen-Regulating Genes Androgen Receptor, Cytochrome P450, and Steroid-5- -Reductase Type 2 Is Important for Prostate Cancer Development |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q29417155 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array |
| Q36062033 | Identification of a novel percent mammographic density locus at 12q24. |
| Q36754771 | Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q39356415 | Improved methods for multi-trait fine mapping of pleiotropic risk loci |
| Q23924183 | Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 |
| Q36384402 | Informed conditioning on clinical covariates increases power in case-control association studies |
| Q81039000 | Inherited variation in hormone-regulating genes and prostate cancer survival |
| Q55693698 | Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival. |
| Q36849912 | Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q33845203 | Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival |
| Q30865659 | Integrating functional data to prioritize causal variants in statistical fine-mapping studies |
| Q36065460 | Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions |
| Q88009010 | Interaction of a genetic risk score with physical activity, physical inactivity, and body mass index in relation to venous thromboembolism risk |
| Q38842066 | Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3. |
| Q97435244 | Interactions Between Mammographic Density Phenotypes and Established Risk Factors on Breast Cancer Risk, by Tumor Subtype and Menopausal Status |
| Q40071035 | Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium |
| Q35166701 | Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium |
| Q36077025 | Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate |
| Q53080453 | Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism. |
| Q40093230 | Investigating the genetic relationship between Alzheimer's disease and cancer using GWAS summary statistics |
| Q60182876 | Is Schizophrenia a Risk Factor for Breast Cancer?—Evidence From Genetic Data |
| Q64279327 | Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk |
| Q57191573 | Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair |
| Q28267893 | Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair |
| Q36043843 | Mammographic breast density and breast cancer: evidence of a shared genetic basis |
| Q30276350 | Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. |
| Q37143043 | Meta-Analysis of Rare Variant Association Tests in Multiethnic Populations |
| Q35266365 | Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism |
| Q64922604 | Metabolites Associated With the Risk of Incident Venous Thromboembolism: A Metabolomic Analysis. |
| Q48522700 | Metabolomic analysis of 92 pulmonary embolism patients from a nested case-control study identifies metabolites associated with adverse clinical outcomes. |
| Q36133352 | Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores |
| Q57760214 | Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores |
| Q115032642 | Multi‐phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations |
| Q35752042 | Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q36225291 | Partitioning heritability by functional annotation using genome-wide association summary statistics |
| Q36831883 | Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q34155371 | Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q37223335 | Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status |
| Q35624758 | Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies |
| Q37633508 | Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II. |
| Q37735483 | Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q38668303 | Quantifying the Genetic Correlation between Multiple Cancer Types |
| Q35661241 | Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). |
| Q33723482 | Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies |
| Q29417074 | Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q36602824 | Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway |
| Q96684370 | Telomere maintenance variants and survival after colorectal cancer: Smoking- and sex-specific associations |
| Q28397509 | Telomere structure and maintenance gene variants and risk of five cancer types |
| Q34372389 | The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease |
| Q37578078 | The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers |
| Q80626180 | The UGT2B17 gene deletion is not associated with prostate cancer risk |
| Q114677146 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q35575585 | Two susceptibility loci identified for prostate cancer aggressiveness |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q42366130 | Up For A Challenge (U4C): Stimulating innovation in breast cancer genetic epidemiology |
| Q41042525 | Variants in 6q25.1 Are Associated with Mammographic Density in Malaysian Chinese Women |
| Q37370221 | Variation in predictive ability of common genetic variants by established strata: the example of breast cancer and age. |
| Q35164176 | Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3). |
| Q35925515 | Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study |
| Q59265049 | Y Chromosome Haplotypes and Prostate Cancer in Sweden |
Search more.